On October 14, 2026, 3DPrint.com released its daily news brief: Myrava (formerly Ricoh 3D for Healthcare) announced that its patient-specific 3D printed radiotherapy bolus received FDA 510(k) clearance; AML3D is advancing an aerospace manufacturing tooling project; Mears Machine has purchased a Velo3D Sapphire XC system dedicated to printing copper-nickel alloy (CuNi) parts; and Canadian researchers have developed a low-cost 3D printed filter that can remove microplastics from water on a large scale. Myrava's radiotherapy bolus is 3D printed directly based on patient anatomy and treatment plans, using a flexible, translucent material that can be reused throughout the same patient's treatment cycle, replacing traditional temporary solutions such as wet cloths and gel sheets. Mears' Sapphire XC system will be dedicated to CuNi part production for its defense and industrial customers. The brief covers multiple lines in medical, aerospace, and metal 3D printing: on the medical side, personalized radiotherapy devices are entering the regulatory clearance pathway, while on the metal side, dedicated CuNi printing capacity continues to expand, reflecting the deepening penetration of additive manufacturing in regulated industries. Value for powder buyers: ① With dedicated equipment installations, CuNi copper-nickel alloy powder is releasing stable demand—pay attention to powder batch consistency and military certification requirements; ② As more medical additive manufacturing clearances occur, more application scenarios are opening up for medical-grade powders such as titanium alloys; ③ This brief is a summary of multiple events, and specific sub-events should be verified one by one against the original announcements.